Search
Medicaid Monitor
Saturday, November 21, 2026 · Updated Fri 12:06 PM MT · 52 stories on Friday, November 20
Medicaid Monitor Pro
Sat, Nov 21 · 52 stories on Friday, November 20PRO
← All stories
LegalOctober 1, 2026

DOJ Memo Prioritizes Healthcare Fraud in Corporate Investigations

An Oct. 1 memo from Assistant Attorney General Colin McDonald directs the Justice Department's National Fraud Enforcement Division to prioritize healthcare fraud, including controlled substance distribution and FDCA violations, as one of four focus areas for corporate investigations. Prosecutors must weigh 10 factors when deciding on charges or plea agreements, including corporate management's knowledge of schemes, efforts to conceal fraud from government auditors, and conduct causing substantial harm to taxpayer-funded programs. The division, formed in April from the former Criminal Division Health Care Fraud Unit, is using data analytics to accelerate new investigations and will develop whistleblower incentive programs, including for participants in misconduct. The policy also directs prosecutors to follow existing self-disclosure and cooperation credit guidance while avoiding overly broad enforcement.

Why it mattersHealthcare organizations, including Medicaid managed care plans and providers, face heightened federal scrutiny and should reassess compliance, disclosure, and whistleblower-response protocols given the new prosecutorial priorities and incentives.

Finance · Pharmacy

Read the full article at beckershospitalreview.com →
Also covered by:foley.com
Share this briefing

You might also like

← All stories

Get the daily briefing.